INNOVENT ENTERED A STRATEGIC COLLABORATION AGREEMENT WITH MD ANDERSON CANCER CENTER TO CO-DEVELOP PD-1Strategic Collaboration Agreement • April 13th, 2019
Contract Type FiledApril 13th, 2019This announcement is made by Innovent Biologics, Inc. (the “Company” or “Innovent”, together with its subsidiaries, the “Group”) on a voluntary basis to inform the shareholders and potential investors of the Company about the latest business updates of the Group.